The Genomics Market is being driven by Rising investments in genomics research and development
The Genomics Market is expected to grow at a CAGR of 3.3% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 6218.8 million. The Human Genome Project (HGP) marked a pivotal moment in genomics research, providing businesses with essential resources for mapping the complete human genome and deciphering genetic functionalities and structures. Next-Generation Sequencing (NGS) technologies, born from the HGP's success, revolutionized the industry by enabling large-scale sequencing of the human genome. This advancement facilitated the detection of mutations and gene variants associated with diseases or disorders, significantly reducing the cost of genetic analysis and database management in the global genomics market. By offering a cost-effective solution, NGS has transformed the landscape of genomics research, fostering a new era of medical breakthroughs.
Get more information on Genomics Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
217 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.3% |
Market growth 2025-2029 |
USD 6218.8 million |
Market structure |
fragmentation |
YoY growth 2024-2025(%) |
3.2 |
Key countries |
US, Germany, China, UK, France, Japan, Canada, India, Mexico, Brazil, US, UK, Germany, France, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Genomics Market encompasses a range of applications, including genome assembly software for sequence analysis, variant effect prediction to identify genetic variations and their impacts, gene ontology enrichment for functional annotation, sequence alignment algorithms for comparing genomes, high-throughput screening for large-scale analysis, data mining techniques for extracting insights, machine learning models and deep learning applications for predictive analysis, statistical modeling methods for population genetics and evolutionary genomics. Additionally, the market caters to various research areas such as cancer genomics, agricultural genomics, environmental genomics, forensic genomics, clinical genomics, diagnostic genomics, biomarker discovery, drug target identification, gene expression regulation, protein-protein interaction, transcription factor binding, genome stability mechanisms, DNA repair pathways, genome evolution dynamics, microbial genome diversity, viral genome characterization, plant genome engineering, and animal genome editing.
The Genomics market, a segment of the larger Global Life Science Tools and Services Market, encompasses companies specializing in genome sequencing, gene expression profiling, DNA microarray technology, and next-generation sequencing. This market caters to the research and development (R&D) sector, providing capital equipment, instruments, accessories, and consumables for pharmaceutical and biotechnology product development and laboratory diagnosis of diseases. The market's growth is driven by factors such as the increasing global population aging, leading to a larger demographic requiring healthcare solutions, and the continuous advancements in genomic research technologies. Technavio projects the healthcare market size based on the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted